Associations between genetic variation and immune response in infants with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI)
Completed
- Conditions
- lower respiratory tract infectionRSV bronchiolitis1004743810024970
- Registration Number
- NL-OMON31227
- Lead Sponsor
- aboratorium voor Gezondheidsbeschermingsonderzoek
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
RSV bronchiolitis in children younger than 13 months of age who are admitted to a hospital.
Exclusion Criteria
Airway morbidity in the past, severe heartdisease or severe lungdisease in the past.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic factors influence immune response to RSV LRTI in infants according to NL-OMON31227?
Are specific polymorphisms in infants associated with RSV bronchiolitis severity and immune modulation?
What biomarkers could predict RSV LRTI outcomes based on genetic and immune profiling from observational studies?
How do host genetic variations affect RSV pathogenesis and potential therapeutic targets in pediatric populations?
What are the implications of RSV genetics study findings for developing personalized immune-based therapies in infants?